Retinal artery occlusion in a patient with factor V leiden and prothrombin G20210A mutations

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 1, 2002, Pages 57-59

  Ben Ami, R ^a   Zeltser, D ^a   Leibowitz, I ^a   Berliner, S A ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Activated protein C resistance; Retinal artery occlusion; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; ENOXAPARIN; PROTHROMBIN; WARFARIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; PARACENTESIS; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RISK FACTOR; THROMBOPHILIA; VISUAL IMPAIRMENT;

ADULT; ANTICOAGULANTS; FACTOR V; HOMOZYGOTE; HUMANS; MALE; PARACENTESIS; POINT MUTATION; PROTHROMBIN; RETINAL ARTERY OCCLUSION; THROMBOPHILIA;

EID: 0036238334     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200201000-00009     Document Type: Article

References (15)

1. Retinal stroke. Is the patient at risk?
2. Transthoracic echocardiographic findings in patients with acute retinal arterial obstruction. A retrospective review
3. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment
4. Retinal arterial occlusions in young adults
5. Resistance to activated protein C as a basis for venous thrombosis
6. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia study
7. Retinal vascular occlusion and deficiencies in the protein C pathway
8. Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations
9. Branch retinal arteriolar occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor
10. Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation
11. Central retinal artery occlusion in a patient homozygous for factor V Leiden
12. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
13. Prothrombin G20210A polymorphism and thrombophilia
14. Interaction of coagulation defects and cardiovascular risk factors: Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A
15. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients